Purposeful Company
Purposeful discovers new treatments and develops pharmaceutical products for rare diseases by repurposing previously marketed drugs. Their vision is to fully utilize AI repurposing and revisit rare and common diseases to reverse disease phenotypes. It collaborates with FRAXA and FRAXA-DVI to identify drug repurposing candidates for Fragile X Syndrome. They also identify drug repurposing candidates for Glioblastoma.
Funding Status:
private
Last Funding Date:
2018-10-18
Headquarters:
Athens,Attiki,Greece,Europe
Total Funding:
200000
Founded Date:
2018-01-01
Industry:
Quantum Biology
Super Industry:
Quantum Science Applications
Funding Stage:
Seed
Funding Total Value:
200000
Last Funding Total Usd:
200000
Last Funding Total Currency:
USD
Last Funding Total Value:
200000
Founders:
Charalampos Chomenidis,George Drakakis